Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-125555
Filing Date
2024-11-12
Accepted
2024-11-12 16:37:34
Documents
6
Effectiveness Date
2024-11-12

Document Format Files

Seq Description Document Type Size
1 S-8 pyxs_s-8_2021_plan_amend.htm S-8 122724
2 EX-5.1 pyxs-ex5_1.htm EX-5.1 20316
3 EX-23.2 pyxs-ex23_2.htm EX-23.2 3439
4 EX-FILING FEES pyxs-exfiling_fees.htm EX-FILING FEES 36174
5 GRAPHIC img83719486_0.jpg GRAPHIC 5579
6 GRAPHIC img83719486_1.jpg GRAPHIC 5579
  Complete submission text file 0000950170-24-125555.txt   199320
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283161 | Film No.: 241449121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)